ClearPoint Neuro, Inc. has announced a significant expansion following the signing of a lease agreement with BRE-BMR SCD LLC. The company will occupy approximately 30,171 square feet in a life science building in San Diego, California, which will be used for office, research and development, and laboratory purposes. The lease will be executed in three phases, with the first phase set to be occupied by June 13, 2025. The lease expires 132 months after the final phase is occupied, with an option for a five-year extension. The initial monthly base rent is set at $5.95 per square foot, subject to annual increases of 3%. ClearPoint Neuro will also cover a pro rata share of operating expenses. This expansion marks a strategic move for the company as it continues to grow its operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.